Late-Onset Multiple Sclerosis After COVID-19 Vaccination
Author Information
Author(s): Scorza Carla Alexandra, Scorza Fulvio Alexandre, Finsterer Josef
Primary Institution: Universidade Federal de São Paulo (UNIFESP/EPM)
Hypothesis
Can SARS-CoV-2 vaccinations trigger new-onset multiple sclerosis in older adults?
Conclusion
This case suggests that SARS-CoV-2 vaccination may trigger the development of multiple sclerosis even in patients over sixty years of age.
Supporting Evidence
- Multiple sclerosis was diagnosed after the patient met Mcdonald's criteria.
- The patient had no prior symptoms of multiple sclerosis before vaccination.
- Positive Oligoclonal Bands were found in the CSF examination.
Takeaway
A 67-year-old woman developed multiple sclerosis after getting COVID-19 vaccines, which is unusual for her age.
Methodology
The patient was diagnosed through clinical examination, MRI, and CSF analysis.
Potential Biases
Potential biases may arise from the lack of control group and reliance on patient self-reporting.
Limitations
The case is based on a single patient, making it difficult to generalize the findings.
Participant Demographics
67-year-old Caucasian woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website